| 5‐Fluorouracil | |
| Generic Name | 5‐Fluorouracil |
| Trade Name | Adrucil |
| Drug Type | Antimetabolite |
| Dose | 400 mg/m2 bolus followed by 2,400 mg/m2 continuous infusion over 46 hours mg/m2 |
| Route | Bolus followed by continuous infusion over 46 hours |
| Schedule of Administration | 5‐Fluorouracil was given on day 1 every 14 days |
| Oxaliplatin | |
| Generic Name | Oxaliplatin |
| Trade Name | Eloxatin |
| Drug Type | Platinum containing compound |
| Dose | 85 mg/m2 |
| Route | IV |
| Schedule of Administration | Oxaliplatin was given on day 1 every 14 days |
| Leucovorin | |
| Generic Name | Leucovorin |
| Trade Name | Folinic acid |
| Drug Type | Folic acid analog |
| Dose | 400 mg/m2 |
| Route | IV |
| Schedule of Administration | Leucovorin was given on day 1 every 14 days |
| Dasatinib | |
| Generic Name | Dasatinib |
| Trade Name | Sprycel |
| Company Name | Bristol‐Myers Squibb |
| Drug Type | Small molecule |
| Drug Class | BCR‐Abl |
| Dose | 150 mg per flat dose |
| Route | oral (po) |
| Schedule of Administration | Dasatinib was given on days 1–14 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.